Plan B Legislation Sets FDA Decision Deadline; Call For Hearings Renewed
This article was originally published in The Tan Sheet
Executive Summary
Members of Congress are urging Democratic Sens. Hillary Clinton (N.Y.), Patty Murray (Wash.) and Carl Levin (Mich.) to introduce companion legislation to a House bill that would deem the Plan B switch application "approved" if FDA does not issue a decision by a certain deadline
You may also be interested in...
FDA “Unable” To Decide On Plan B, Seeks Comment On Dual-Status Drugs
FDA believes additional information on whether a drug can be marketed both Rx and OTC for the same indication is needed before a decision can be reached on Barr Labs' switch application for Plan B
Fraud Discovery Institute Asks Waxman To Address Lead In Herbalife Products
FDA should issue a public health alert to warn consumers about potential health risks that may result from use of Herbalife dietary supplements and should remove the company's products from the market, pending further investigation of lead contamination, according to Christopher Grell, an attorney whose firm specializes in ephedra and dietary supplement litigation
Fraud Discovery Institute Asks Waxman To Address Lead In Herbalife Products
FDA should issue a public health alert to warn consumers about potential health risks that may result from use of Herbalife dietary supplements and should remove the company's products from the market, pending further investigation of lead contamination, according to Christopher Grell, an attorney whose firm specializes in ephedra and dietary supplement litigation